Close X
Monday, December 2, 2024
ADVT 
International

Leave Kharkiv under all circumstances by 6 pm: Indian Embassy to citizens

Darpan News Desk IANS, 02 Mar, 2022 05:45 PM
  • Leave Kharkiv under all circumstances by 6 pm: Indian Embassy to citizens

New Delhi, March 2 (IANS) In a distress call, the Indian Embassy in Ukraine has directed all stranded citizens to leave the second most populous city, Kharkiv under all circumstances by 6 p.m. (Ukrainian time, IST 9.30 p.m.) on Wednesday.

The embassy stated: "Urgent advisory to all Indian nationals in Kharkiv. For their safety and security they must leave Kharkiv immediately. Proceed to Pesochin, Babaye and Bezlyudovka as soon as possible."

It reiterated, "Under all circumstances they must reach these settlements by 1800 hours (Ukrainian time) today."

Kharkiv, a largely Russian-speaking city near the Russian border, has a population of around 1.4 million. It has been found that Russian troops have landed in Kharkiv and are engaged in heavy fighting with Ukrainian forces.

Russia shelled Kharkiv damaging various installations.

Further, videos are circulating online of an apparent attack on the regional police and intelligence headquarters in Kharkiv.

"Practically there are no areas left in Kharkiv where an artillery shell has not yet hit," Anton Gerashchenko, adviser to the Ukrainian interior minister, said in a statement posted on Telegram.

However, Russia says it is only targeting Ukraine's military infrastructure, air defence and air forces with high-precision weapons.

It was in Kharkiv where an Indian student was killed on Tuesday morning in shelling. Naveen Shekharappa Gyanagoudar, a 21-year-old medical student from Karnataka, was standing in the queue for food in Kharkiv on Tuesday morning when he was killed.

Naveen was a final year medical student at the Kharkiv National Medical University. He was from Karnataka's Haveri and lived near a prominent government building that was blown up by Russian soldiers.

The war between two countries has entered into the sixth day after Russian President Vladimir Putin called for military operation.

MORE International ARTICLES

Extra safety scrutiny planned as virus vaccine worries grow

Extra safety scrutiny planned as virus vaccine worries grow
The poll from The Associated Press-NORC Center for Public Affairs Research found only 46% of Americans want a COVID-19 vaccine and another 29% are unsure.

Extra safety scrutiny planned as virus vaccine worries grow

Retiree checks to rise 1.3% in 2021 amid coronavirus fallout

Retiree checks to rise 1.3% in 2021 amid coronavirus fallout
The COLA affects the personal finances of about 1 in 5 Americans, including Social Security recipients, disabled veterans and federal retirees, some 70 million people in all.

Retiree checks to rise 1.3% in 2021 amid coronavirus fallout

AP-NORC poll: New angst for caregivers in time of COVID-19

AP-NORC poll: New angst for caregivers in time of COVID-19
The Associated Press-NORC Center for Public Affairs Research poll finds that 17% of Americans say they are providing ongoing caregiving, part of an informal volunteer corps.

AP-NORC poll: New angst for caregivers in time of COVID-19

Am I immune to the coronavirus if I’ve already had it?

Am I immune to the coronavirus if I’ve already had it?
Reinfection so far has been rare. The best known example: Researchers in Hong Kong said a man had mild COVID-19 and then months later was infected again but showed no symptoms.

Am I immune to the coronavirus if I’ve already had it?

Antibody drugs are no cure but seem promising for COVID-19

Antibody drugs are no cure but seem promising for COVID-19
Antibodies are proteins the body makes when an infection occurs; they attach to a virus and help it be eliminated. Vaccines mimic an infection to spur antibody production.

Antibody drugs are no cure but seem promising for COVID-19

Lilly seeks emergency use of its antibody drug for COVID-19

Lilly seeks emergency use of its antibody drug for COVID-19
Eli Lilly and Company announced the partial results Wednesday in a news release; they have not yet been published or reviewed by independent scientists.

Lilly seeks emergency use of its antibody drug for COVID-19